The Clinical and Laboratory Standards Institute published in 2008 new interpretive criteria for the identification of methicillin resistance in staphylococci isolated from animals. The sensitivity of the 2008 interpretive criteria for mecA gene-positive Staphylococcus pseudintermedius, compared with the previous criteria of 2004, was investigated. Thirty clinical isolates of methicillin-resistant S. pseudintermedius from dogs were used. The presence of the mecA gene was determined by polymerase chain reaction. The minimum inhibitory concentration for oxacillin was determined by broth microdilution. The 2008 breakpoint of $4 mg/ ml for methicillin resistance resulted in a diagnostic sensitivity of 73.3% (22/30). The 2004 breakpoint guideline of $0.5 mg/ml resulted in a diagnostic sensitivity of 97% (29/30). For oxacillin disk diffusion, the 2008 interpretive criterion of #10 mm for methicillin resistance resulted in a sensitivity of 70% (21/30). If intermediate isolates (11 or 12 mm) were considered resistant, the sensitivity was 93% (28/30). Application of the 2004 interpretive criterion of #17 mm resulted in a diagnostic sensitivity of 100% (30/30). For cefoxitin disk diffusion, the interpretive criterion of #21 mm for methicillin resistance (as used for Staphylococcus aureus) resulted in a diagnostic sensitivity of 6.7% (2/30). The interpretive criterion of #24 mm (as used for coagulase-negative staphylococci) resulted in a diagnostic sensitivity of 43.3% (13/30). With the use of 2008 interpretive criteria, all 3 tests produced what we consider to be an unacceptable level of false negative results. Our findings also suggest that cefoxitin disk diffusion is an inappropriate screening test for methicillin resistance of canine S. pseudintermedius.
<!?show "fnote_aff1"$^!"content-markup(./author-grp [1] /aff|./author-grp [1] /dept-list)> Staphylococcus pseudintermedius, previously identified as Staphylococcus intermedius, 9, 10, 20 is the most common etiologic agent in canine pyoderma 21 and an agent commonly involved in canine otitis. 17, 22 Methicillin-resistant S. pseudintermedius (MRSP) has been increasingly reported as a primary pathogen in canine infections. 2, 12, 13, 19, 23, 24 All methicillin-resistant staphylococci are, by convention, regarded to be resistant to all b-lactam antibiotics in vivo. 5, 7 Cephalosporins are the most common antimicrobials used to treat S. pseudintermedius infections in dogs 18 but are not efficacious for the treatment of MRSP infections. Thus, accurate determination of methicillin resistance is of critical importance to the clinician and the canine patient.
Methicillin resistance is imparted by penicillin-binding protein 2a (PBP2a), which is encoded by the gene mecA. 15 The gold standard for diagnosis of methicillin resistance is detection of mecA via polymerase chain reaction (PCR). 6, 7 Veterinary microbiology laboratories rely on a variety of laboratory tests to identify methicillin resistance, and few laboratories at this time, if any, are known to perform PCR for mecA on a routine diagnostic basis. The most commonly used laboratory tests use oxacillin as a surrogate for methicillin in the following formats: broth microdilution (MIC), disk diffusion, and testing on oxacillin salt agar. Disk diffusion testing with the use of cefoxitin as a surrogate for oxacillin has also been suggested. 7 The Clinical and Laboratory Standards Institute (CLSI) has published new (2008) performance standards for antimicrobial susceptibility testing of bacteria isolated from animals, 7, 8 and new interpretive criteria for the determination of oxacillin susceptibility and resistance in staphylococci were specified. The specimens included in this study were selected from a pathogen data bank of clinical isolates collected from February 2007 to September 2008 from the clinical microbiology laboratory at the Veterinary Teaching Hospital at The Ohio State University. The bank included all isolates of coagulase-positive staphylococci that were suspected to be methicillin resistant on the basis of resistance or intermediate susceptibility to oxacillin on disk diffusion test and, in some instances, oxacillin salt agar testing. Subsequently, mecA PCR was performed on all banked isolates. Isolates were frozen at 280uC in trypticase soy broth and 20% dimethyl sulfoxide for up to 20 months and were prepared from a single colony.
The criteria used for selection of isolates included that each isolate 1) originated from a unique canine patient, 2) was associated with clinically apparent infection of the skin (wounds, lesions of pyoderma, incisions) or ear (external ear canal, middle ear), 3) was positive for mecA, and 4) was identified as S. pseudintermedius.
The isolates were subcultured from freezer storage and streaked onto trypticase soy agar supplemented with 5% sheep's blood. a One isolated colony was further subcultured for subsequent biochemical identification and susceptibility testing.
Reagents from commercial sources were used whenever possible for biochemical testing, and all incubations occurred at 35uC in ambient air. The coagulase test a was interpreted at 24 hr. Phenol-red b tests of trehalose c and lactose c fermentation were interpreted at 48 hr. Mannitol salt agar a was used to assess fermentation of mannitol and was interpreted at 48 hr. The Voges-Proskauer test d was interpreted after 48 hr of incubation. Quality control strains S. intermedius ATCC (American Type Culture Collection) 29663, Staphylococcus schleiferi subsp. coagulans ATCC 49545, and S. aureus ATCC 8325 were included as controls for identification.
Microdilution testing for oxacillin MIC assessment was performed with Mueller-Hinton broth e supplemented with 5% NaCl. The MIC was determined for each isolate in a semiautomated system. f CLSI protocols and instrument manufacturer instructions were followed.
Bacteria were suspended in sterile, deionized water and adjusted to a 0.5 McFarland standard for Kirby-Bauer disk diffusion testing. Suspensions were swabbed onto Mueller-Hinton agar a to make lawns, and disks containing oxacillin (1 mg) and cefoxitin (30 mg) were applied. a The plate was assessed after 24 hr of incubation at 35uC, and the zone of inhibition diameter for each antimicrobial disc was recorded in millimeters.
Isolates were evaluated for methicillin resistance using 2008 CLSI S. aureus-based interpretive criteria and 2004 Staphylococcus spp.-based criteria for oxacillin broth microdilution testing and Kirby-Bauer disk diffusion tests. Isolates were also evaluated on the cefoxitin disk diffusion test comparing the interpretive criteria used for S. aureus and coagulase-negative staphylococci (CNS; Table 1 ).
Before DNA extraction for mecA PCR, isolates were subcultured in brain heart infusion broth. Genomic DNA was prepared with the use of a commercially available extraction kit per manufacturer instructions for Grampositive bacteria. g The mecA PCR was performed with previously described primers: 16 (mecA-F: TCCAGATTA CAACTTCACCAGG and mecA-R: CCACTTCA TATCTTGTAACG with an expected amplicon size of 162 base pairs). Included in all PCR reactions were positive Thirty isolates met all the criteria and thus were included in the study. All isolates were identified as S. pseudinter-medius (previously S. intermedius in dogs) and were coagulase positive, VP negative, positive for fermentation of lactose and trehalose, and negative for fermentation of mannitol. The specific results and interpretation of each test for each isolate are presented in Table 2 .
The 2008 breakpoint of $4 mg/ml for methicillin resistance resulted in a diagnostic sensitivity of 73.3% (22/ 30) for mecA-positive S. pseudintermedius. The 2004 breakpoint guideline of $0.5 mg/ml for methicillin resistance resulted in a diagnostic sensitivity of 97% (29/30). The 2008 CLSI interpretive guideline of #10 mm for methicillin resistance resulted in a diagnostic sensitivity of 70% (21/30) for mecA-positive S. pseudintermedius. If intermediate isolates (11- or 12-mm zone of inhibition) are considered resistant (as might occur in clinical interpretations), the diagnostic sensitivity was 93% (28/ 
30). Application of the 2004 interpretive criterion of
#17 mm for methicillin resistance in S. aureus resulted in a diagnostic sensitivity of 100% (30/30). The interpretive criterion of #21 mm for methicillin resistance (as used for S. aureus) resulted in a diagnostic sensitivity of 6.7% (2/30) for mecA-positive S. pseudintermedius. The interpretive criterion of #24 mm for methicillin resistance (as used for coagulase-negative staphylococci) resulted in a diagnostic sensitivity of 43.3% (13/30).
The 2008 interpretive criteria failed to detect methicillin resistance in some clinical mecA-positive isolates of S. pseudintermedius from the skin and ears of dogs. The most sensitive method for phenotypic recognition of methicillin resistance in this limited cohort of mecA-positive S. pseudintermedius isolates was oxacillin Kirby-Bauer disk diffusion under the 2004 interpretive criteria, with 100% sensitivity; the 2008 criteria failed to identify 2 methicillinresistant isolates. The 2008 interpretive criteria for oxacillin broth microdilution failed to identify methicillin resistance in 26.6% of isolates in this study. The 2004 interpretive criteria were more sensitive, although methicillin resistance was unrecognized in a single isolate (isolate 1).
Cefoxitin disk diffusion was the least sensitive method. Interpretive criteria specific for veterinary staphylococci, including S. pseudintermedius, remain to be established. Use of CNS and S. aureus interpretive guidelines in this cohort of isolates failed to identify methicillin resistance in 57.7% and 93.3% of isolates, respectively. This finding is consistent with a previous study, 3 wherein the sensitivity of CNS interpretive criteria in PBP2a-positive S. intermedius was found to be 44% (9 isolates tested) and 17% (24 isolates tested). In contrast, cefoxitin disk diffusion has been reported to be 84.6-100% sensitive and 87.5-100% specific for mecA-positive and -negative human origin S. aureus, respectively. 1, 4 In a previous study, 3 cefoxitin disk diffusion was 100% specific in 74 isolates with CNS interpretive criteria. Specificity could not be assessed in the work presented here because mecA-negative isolates were not evaluated. The use of cefoxitin disk diffusion for detecting the methicillin-resistant phenotype of S. pseudintermedius from dogs requires further investigation.
Isolate 1, though mecA-positive, was not identified as methicillin resistant with oxacillin broth microdilution 2004 nor 2008 interpretive criteria. Discordance between the presence of mecA and the absence of a corresponding oxacillin-resistant phenotype has been recognized previously in veterinary isolates of S. aureus, S. intermedius, and S. schleiferi, 3 as well as human isolates of S. aureus. 11 However, in isolate 1, methicillin resistance was detected via oxacillin disk diffusion (2004 and 2008 interpretive criteria) and via cefoxitin disk diffusion (2004 CNS interpretive criteria), which is consistent with a PBP2apositive phenotype.
mecA-negative clinical isolates were not evaluated in the current study. Therefore specificity and expectation for false positive results for these methods was not determined. A cohort of 44 mecA-negative canine S. pseudintermedius isolates was recently evaluated. 2 The specificity of oxacillin broth microdilution was 99.4%, and 100% with 2004 and 2008 criteria, respectively. 2 The superior sensitivity of the 2004 oxacillin Kirby-Bauer disk diffusion criteria was similarly demonstrated in 230 mecA-positive canine S. pseudintermedius isolates in a recent study. 2 Oxacillin Kirby-Bauer disk diffusion resulted in a sensitivity of 99.1% and 85.1% with 2004 and 2008 criteria, respectively. 2 Bemis et al. 2 evaluated cefoxitin disk diffusion in 88 mecA-positive and 204 mecA-negative canine S. pseudintermedius isolates. Although highly specific (100%), the cefoxitin Kirby-Bauer disk diffusion method was also found to be the least sensitive method; sensitivities were 85.3% and 70.9% under 2004 and 2008 criteria, respectively. 2 Of note, the diagnostic sensitivities for cefoxitin disk testing reported previously 2 (85.3% and 70.9%) are higher than that of the work presented here (6.7% and 43.3%). The reason for this difference is speculative and might reflect increased accuracy via larger cohort size of that study or regional strain differences. The study also did not restrict number of isolates included per patient; however, the frequency of such inclusions was not reported. Inclusion of concurrent or subsequent isolates from the same individual might have inadvertently selected for clonal isolates that were cefoxitin-sensitive. However, clonality is not restricted to the individual, and evaluation of clonality was not undertaken in this study, nor in a previous study. 2 Despite this disagreement in sensitivity, the work presented in the current study confirms the superior sensitivity of oxacillin Kirby-Bauer disk diffusion interpreted with 2004 CLSI criteria and the inferior sensitivity of cefoxitin disk diffusion in the evaluation of methicillin resistance in canine-origin S. pseudintermedius isolates in a geographically separate population.
With the use of 2008 interpretive criteria, all 3 test methods evaluated would have given what we consider to be an unacceptable level of false-negative results, which could have led to inappropriate treatment if susceptibility to other b-lactam antibiotics was identified and reported in isolates falsely determined to be methicillin susceptible. Our study suggests that application of the 2004 CLSI criteria for oxacillin disk diffusion and oxacillin broth microdilution test produces superior sensitivity for the detection of methicillin-resistant S. pseudintermedius compared with the 2008 criteria. Furthermore, the findings presented in the current study demonstrate that an unacceptably higher rate of false-negative results occur with application of the 2008 CLSI criteria, consistent with recent work. 2 Therefore, it is advised that veterinary diagnostic laboratories abstain from using the 2008 CLSI criteria when evaluating methicillin resistance in canine S. pseudintermedius. The 2004 CLSI criteria for oxacillin Kirby-Bauer disk diffusion and oxacillin broth microdilution should be used to evaluate methicillin resistance in canine S. pseudintermedius isolates. In addition, findings in the present study confirm that cefoxitin disk diffusion, regardless of CNS or S. aureus CLSI interpretive guidelines, is an inappropriate screening test for methicillin resistance in S. pseudintermedius isolated from dogs. 
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